Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

3: Community-acquired pneumonia.

Paul D R Johnson1, Lou B Irving, John D Turnidge

  • 1Infectious Diseases Department, Austin and Repatriation Medical Centre, Melbourne, VIC. Paul.Johnson@armc.org.au

The Medical Journal of Australia
|May 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful treatment with joint retention of Mycobacterium ulcerans prosthetic joint infection in a patient with rheumatoid arthritis.

PLoS neglected tropical diseases·2025
Same author

Buruli ulcer.

Nature reviews. Disease primers·2025
Same author

Defining new Buruli ulcer endemic areas in urban southeastern Australia using bacterial genomics-informed possum excreta surveys.

Applied and environmental microbiology·2025
Same author

Performance of the Australian hospital-acquired complication algorithm for detecting hospital-onset bloodstream infections.

Infection, disease & health·2025
Same author

Perceptions of a Buruli ulcer controlled human infection model: How, who, and why?

PLoS neglected tropical diseases·2025
Same author

Buruli ulcer in Australia: Evidence for a new endemic focus at Batemans Bay, New South Wales.

PLoS neglected tropical diseases·2024

Community-acquired pneumonia (CAP) is diagnosed via chest x-ray and managed based on risk assessment. Treatment involves targeted antibiotics, with specific therapies for severe or unusual infections.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Community-acquired pneumonia (CAP) is a common infection with diverse causative agents, including Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae, and respiratory viruses.
  • Accurate diagnosis and risk stratification are crucial for effective CAP management.

Observation:

  • Chest X-ray is essential for diagnosing pneumonia.
  • A validated risk score incorporating patient age, comorbidities, clinical signs, and investigations aids in determining appropriate management pathways.
  • Low-risk patients can often be treated with oral antibiotics on an outpatient basis, while high-risk individuals may require hospitalization and intravenous therapy.

Findings:

  • Amoxicillin is the recommended oral antibiotic for Streptococcus pneumoniae infections, with benzylpenicillin for intravenous use.

Related Experiment Videos

  • Initial CAP therapy should include a tetracycline (e.g., doxycycline) or macrolide (e.g., roxithromycin).
  • Specific antibiotic additions are recommended for suspected staphylococcal (flucloxacillin/dicloxacillin), gram-negative (gentamicin), or severe cases (third-generation cephalosporin plus intravenous erythromycin).

    • Implications:

    • Timely and appropriate antibiotic selection, guided by risk assessment and suspected pathogens, is key to successful CAP treatment.
    • Consideration of less common but serious infections (e.g., tuberculosis, Legionella, Pneumocystis carinii) is vital for comprehensive patient care.
    • Effective management strategies can reduce morbidity and mortality associated with community-acquired pneumonia.